Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Tailored Intervention Improves Asthma Self-Management for Older Patients

Key clinical point: Older patients with uncontrolled asthma who underwent a tailored intervention that addressed their barriers to self-management had better asthma control and outcomes.

Major finding: Significantly better asthma control scores was seen in the intervention group than the control groups at 3 months (difference-in-differences, 1.2; 95% CI, 0.2-2.2; P = .02), 6 months (1.0; 95% CI, 0.0-2.1; P = .049), and 12 months (0.6; 95% CI, −0.5 to 1.8; P = .28).

Study details: A randomized controlled trial of 391 patients in New York City with uncontrolled asthma between February 2014 and December 2017.

Disclosures: This study was funded in part by the Patient-Centered Outcomes Research Institute. Nandini Shroff reported grants from the Patient-Centered Outcomes Research Institute; Michael S. Wolf reported grants from Eli Lilly; and Juan P. Wisnivesky reported personal fees from Sanofi, Quintiles, and Banook, and grants from Sanofi and Quorum. The other authors reported no relevant conflicts of interest.

Citation:

Federman AD et al. JAMA Intern Med. 2019; doi: 10.1001/jamainternmed.2019.1201.